Case report Gastrointestinal stromal tumors (GISTs) occur exceedingly rare in children and adolescents. Eighty five percent of pediatric GISTs and 15 % of adult GISTs lack oncogenic mutations in KIT and PDGFRA. The results of tyrosine kinase inhibitor therapy in GIST cases with SDH deficiency are limited and controversial. Here, we would like to present a pediatric SDH deficient GIST case treated with surgery and Imatinib Mesylate. We obtained a good response with Imatinib Mesylate.
Journal Information
Vol. 44. Issue S1.
Pages S42 (October 2022)
Vol. 44. Issue S1.
Pages S42 (October 2022)
SOFT TISSUE SARCOMASPP 34
Open Access
SUCCINATE DEHYDROGENASE SUBUNIT B DEFICIENT PEDIATRIC GIST
Visits
489
This item has received
Article information
Special issue
Full text is only aviable in PDF